Avego Bioscience Capital (investor - Private Equity)

avego.com

See something wrong or missing? Let us know

Offices:New York

Avego Bioscience Capital is an American private equity company doing mid to late stage private biotech investments

Average round investment:150.5M USD

Average number per year:1.0

Distribution: 2025 (1)2024 (1)

Portfolio companies: United Kingdom

CellCentric Switzerland

Mostly invests in:

United Kingdom (1) Biotech (2)

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.